Gemmer Asset Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Gemmer Asset Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	–	–	1466
2019 Q3	$0	Buy	+1	New	+$21	﹤0.01%	1509

Other funds holding AKCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Gemmer Asset Management's AKCA Position: Q4 2019 in Review

Gemmer Asset Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2019, closing a stake of 1 share.

Gemmer Asset Management first reported a position in AKCA in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 75 funds tracked by Wall St. Rank hold AKCA as of Q4 2019.

Gemmer Asset Management reported no remaining Akcea Therapeutics Inc position as of Q4 2019 after selling out during the quarter.
Gemmer Asset Management sold 1 Akcea Therapeutics Inc share in Q4 2019.
Gemmer Asset Management first reported a position in Akcea Therapeutics Inc in Q3 2019 and held it in 1 quarter.
Gemmer Asset Management's Akcea Therapeutics Inc position peaked at $0 in Q3 2019.
75 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.